Early cognitive function tests predict early progression in glioblastoma
Author(s) -
SoonTae Lee,
ChulKee Park,
JinWook Kim,
Min-Jung Park,
Hyon Lee,
JungAh Lim,
Seung Hong Choi,
Tae Min Kim,
SeHoon Lee,
SungHye Park,
Il Han Kim,
KyoungMin Lee
Publication year - 2015
Publication title -
neuro-oncology practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 14
eISSN - 2054-2585
pISSN - 2054-2577
DOI - 10.1093/nop/npv007
Subject(s) - medicine , stroop effect , glioma , oncology , trail making test , concomitant , progression free survival , temozolomide , tumor progression , memory span , cognition , logistic regression , multivariate analysis , univariate analysis , radiation therapy , chemotherapy , neuropsychology , working memory , cancer , psychiatry , cancer research
Early progression of glioblastoma prevents patients from completing the standard chemoradiation protocol. Given that cognitive function is associated with prognosis in glioblastoma, we investigated the usefulness of preoperative cognitive function tests for predicting the early progression of glioblastoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom